Treatment of Varicella–Zoster Virus Infection in Severely Immunocompromised Patients
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
In a prospective, randomized trial, we compared intravenous acyclovir and vidarabine in the treatment of varicella-zoster virus infection in severely immunocompromised patients who presented within 72 hours of onset of the infection. Eleven patients were treated in each group. Cutaneous dissemination of infection occurred in none of the 10 acyclovir recipients and in 5 of the 10 vidarabine recipients who had presented with localized dermatomal disease (P = 0.016). As compared with vidarabine, acyclovir treatment shortened the median periods during which cultures were positive for the virus (four vs. seven days, P = 0.004) and new lesions formed (three vs. six days, P = 0.03). Acyclovir also shortened the median interval until the first decrease in pain (4 vs. 7 days, P = 0.005), the pustulation of all lesions (4 vs. 7 days, P = 0.0004), the crusting of all lesions (7 vs. 17 days, P = 0.0003), and the complete healing of lesions (17 vs. 28 days, P = 0.003). In addition, acyclovir reduced the incidence of fever (two vs. eight patients, P = 0.015). We conclude that acyclovir is better than vidarabine for the treatment of varicella-zoster infection in immunocompromised patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Bone-Marrow Transplantation: (First of Two Parts)
Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, F. L., Neiman, P. E., Lerner, K. G., Glucksberg, H., & Buckner, C. D. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504172921605 · Cited by 1,693
ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS
Sköldenberg, B., Alestig, K., Burman, L., Forkman, A., Lövgren, K., Norrby, R., Stiernstedt, G., Forsgren, M., Bergström, T., Dahlqvist, E., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92623-0 · Cited by 610
Weller, T. H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092205 · Cited by 493
Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients
Balfour, H. H., Bean, B., Laskin, O. L., Ambinder, R. F., Meyers, J. D., Wade, J. C., Zaia, J. A., Aeppli, D., Kirk, L. E., Segreti, A. C., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082404 · Cited by 414
Self-citationVaricella in Children With Cancer: Seventy-Seven Cases
Feldman, S., Hughes, W. T., & Daniel, C. B. (1976) · PEDIATRICS · doi:10.1542/peds.57.2.196 · Cited by 370
Varicella in Children With Cancer: Seventy-Seven Case
Feldman, S., Hughes, W. T., & Daniel, C. B. (1975) · Pediatrics · doi:10.1542/peds.56.3.388 · Cited by 370
Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer
Merigan, T. C., Rand, K. H., Pollard, R. B., Abdallah, P. S., Jordan, G. W., & Fried, R. P. (1978) · New England Journal of Medicine · doi:10.1056/nejm197805042981801 · Cited by 365
Herpes Zoster-Varicella Infections and Lymphoma
GOFFINET, D. R., GLATSTEIN, E. J., & MERIGAN, T. C. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-2-235 · Cited by 209
Herpes zoster at the NIH: A 20 year experience
Mazur, M. H., & Dolin, R. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90791-x · Cited by 176
Renal function after acyclovir intravenous injection
Brigden, D., Rosling, A. E., & Woods, N. C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90087-0 · Cited by 171
Prolonged Herpes-Zoster Infection Associated with Immunosuppressive Therapy
Gallagher, J., & MERIGAN, T. C. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-6-842 · Cited by 80
ACYCLOVIR TREATMENT OF VARICELLA-ZOSTER VIRUS INFECTION IN THE COMPROMISED HOST1
Meyers, J. D., Wade, J. C., Shepp, D. H., & Newton, B. (1984) · Transplantation · doi:10.1097/00007890-198406000-00009 · Cited by 59
Self-citation
Cited by
Arvin, A. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.3.361 · Cited by 1,162
Recommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869
Cohen, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1302674 · Cited by 734
Heininger, U., & Seward, J. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69561-5 · Cited by 564
Wood, A. J. J., Whitley, R. J., & Gnann, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271108 · Cited by 410
Metadata
- Authors
- Shepp, D. H., Dandliker, P. S., & Meyers, J. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1986-01-23
- Volume
- 314
- Issue
- 4
- Pages
- 208-212
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2337397650
- Cited by
- 307
- References
- 13
- FWCI
- 29.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.